Immix Biopharma, Inc. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2020 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Immix Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2020 to 2023.
- Immix Biopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$3.83M, a 82.9% decline year-over-year.
- Immix Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$11.4M, a 53.5% decline from 2022.
- Immix Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$7.41M, a 366% decline from 2021.
- Immix Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$1.59M, a 293% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)